Author Question: The nurse should monitor clients receiving dantrolene for hepatic adverse effects: a. within days ... (Read 41 times)

washai · **on:** Jul 24, 2018

The nurse should monitor clients receiving dantrolene for hepatic adverse effects:

a. within days of initiating therapy. c. 3-12 months after initiating therapy.
b. 3-4 weeks after initiating therapy. d. after therapy has been discontinued.

Question 2

When preparing a client for the administration of atrocurium, the nurse should:

a. prepare emergency equipment to support the client's respiratory system.
b. administer neostigmine intravenously.
c. prepare the atrocurium for intramuscular administration.
d. prepare the client for paralysis of smooth muscles.

joechoochoy · **Reply #1 on:** Jul 24, 2018

Answer to Question 1

ANS: C

Feedback
A Incorrect: These effects don't occur this early.
B Incorrect: These effects don't occur this early.
C Correct: This is the appropriate time frame to monitor clients receiving dantrolene.
D Incorrect: These effects don't occur after discontinuing the drug.

Answer to Question 2

ANS: A

Feedback
A Correct: Because of the risk of respiratory muscle blockade, the nurse needs to be sure this equipment is available.
B Incorrect: This is an antidote and is only given in the event the atrocurium needs to be reversed.
C Incorrect: Atrocurium should never be administered IM.
D Incorrect: This agent paralyzes skeletal muscles.